1. Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitors. (June 2020) Authors: Maillet, Denis; Corbaux, Pauline; Stelmes, Jean-Jacques; Dalle, Stéphane; Locatelli-Sanchez, Myriam; Perier-Muzet, Marie; Duruisseaux, Michaël; Kiakouama-Maleka, Lize; Freyer, Gilles; Boespflug, Amélie; Péron, Julien Journal: European journal of cancer Issue: Volume 132(2020) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life setting. (November 2019) Authors: Corbaux, Pauline; Maillet, Denis; Boespflug, Amélie; Locatelli-Sanchez, Myriam; Perier-Muzet, Marie; Duruisseaux, Michaël; Kiakouama-Maleka, Lize; Dalle, Stéphane; Falandry, Claire; Péron, Julien Journal: European journal of cancer Issue: Volume 121(2019) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Tumor-free osteosclerotic lesions in patients treated for metastatic melanoma using BRAF inhibitors. Issue 1 (February 2017) Authors: Bottlaender, Lea; Perier-Muzet, Marie; Lapras, Véronique; Thomas, Luc; Dalle, Stephane Journal: Melanoma research Issue: Volume 27:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗